
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $564.5M | $573.7M | $620.7M | $670.4M | $748.4M | |
Revenue Growth (YoY) | 34.26% | 1.62% | 8.2% | 8% | 11.65% | |
Cost of Revenues | $248M | $255.1M | $263.5M | $281.9M | $323.3M | |
Gross Profit | $316.6M | $318.6M | $357.2M | $388.4M | $425.1M | |
Gross Profit Margin | 56.08% | 55.53% | 57.54% | 57.94% | 56.8% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $79.7M | $87.3M | $95.4M | $98.7M | $105.8M | |
Other Inc / (Exp) | $6.5M | $17.3M | $15.6M | $7.7M | $3.8M | |
Operating Expenses | $198.9M | $212.7M | $232.4M | $239M | $254.6M | |
Operating Income | $117.7M | $105.9M | $124.8M | $149.4M | $170.5M | |
Net Interest Expenses | $54.3M | $54.3M | $58.1M | $66.1M | $71.4M | |
EBT. Incl. Unusual Items | $69.9M | $68.8M | $82.3M | $90.9M | $102.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $8.4M | $8.4M | $8.5M | $6M | $9M | |
Net Income to Company | $61.5M | $60.5M | $73.8M | $85M | $94M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $61.5M | $60.5M | $73.8M | $85M | $94M | |
Basic EPS (Cont. Ops) | $2.16 | $2.04 | $2.44 | $2.69 | $2.87 | |
Diluted EPS (Cont. Ops) | $2.14 | $2.03 | $2.43 | $2.68 | $2.87 | |
Weighted Average Basic Share | $28.5M | $29.6M | $30.3M | $31.6M | $32.7M | |
Weighted Average Diluted Share | $28.7M | $29.7M | $30.4M | $31.7M | $32.8M | |
EBITDA | $215.8M | $219.7M | $246.8M | $265.2M | $289.4M | |
EBIT | $124.2M | $123.2M | $140.4M | $157.1M | $174.3M | |
Revenue (Reported) | $564.5M | $573.7M | $620.7M | $670.4M | $748.4M | |
Operating Income (Reported) | $117.7M | $105.9M | $124.8M | $149.4M | $170.5M | |
Operating Income (Adjusted) | $124.2M | $123.2M | $140.4M | $157.1M | $174.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $114.8M | $124.3M | $137.3M | $149.4M | $167.6M | |
Revenue Growth (YoY) | -0.84% | 8.29% | 10.45% | 8.8% | 12.2% | |
Cost of Revenues | $49.9M | $53M | $53.1M | $58.5M | $66.5M | |
Gross Profit | $64.9M | $71.3M | $84.2M | $90.9M | $101.1M | |
Gross Profit Margin | 56.56% | 57.33% | 61.34% | 60.85% | 60.34% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $20.9M | $24.2M | $24.3M | $25.8M | $27.8M | |
Other Inc / (Exp) | $2.1M | $7.4M | $3.2M | $3.6M | $2.4M | |
Operating Expenses | $51.8M | $60.1M | $59M | $63M | $65.2M | |
Operating Income | $13.1M | $11.1M | $25.2M | $27.9M | $35.9M | |
Net Interest Expenses | $13.4M | $13.7M | $15.8M | $17.6M | $18.3M | |
EBT. Incl. Unusual Items | $1.7M | $4.8M | $12.6M | $13.9M | $20M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$896K | $1.1M | $1.1M | $2.2M | $3.5M | |
Net Income to Company | $2.6M | $3.7M | $11.5M | $11.7M | $16.6M | |
Minority Interest in Earnings | $38K | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $2.7M | $3.7M | $11.5M | $11.7M | $16.6M | |
Basic EPS (Cont. Ops) | $0.09 | $0.12 | $0.37 | $0.36 | $0.49 | |
Diluted EPS (Cont. Ops) | $0.09 | $0.12 | $0.37 | $0.36 | $0.49 | |
Weighted Average Basic Share | $28.9M | $30.2M | $30.9M | $32.1M | $33.8M | |
Weighted Average Diluted Share | $29M | $30.3M | $31M | $32.1M | $33.9M | |
EBITDA | $39.1M | $46.6M | $55.2M | $60.4M | $67.9M | |
EBIT | $15.2M | $18.5M | $28.4M | $31.5M | $38.3M | |
Revenue (Reported) | $114.8M | $124.3M | $137.3M | $149.4M | $167.6M | |
Operating Income (Reported) | $13.1M | $11.1M | $25.2M | $27.9M | $35.9M | |
Operating Income (Adjusted) | $15.2M | $18.5M | $28.4M | $31.5M | $38.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $563.6M | $583.2M | $633.7M | $682.4M | $766.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $247.9M | $258.3M | $263.6M | $287.3M | $331.3M | |
Gross Profit | $315.6M | $324.9M | $370.1M | $395.1M | $435.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $79M | $90.6M | $95.5M | $100.1M | $107.8M | |
Other Inc / (Exp) | $7.8M | $22.6M | $11.4M | $8.1M | $2.6M | |
Operating Expenses | $200.3M | $221M | $231.3M | $242.9M | $256.9M | |
Operating Income | $115.3M | $103.9M | $138.8M | $152.2M | $178.5M | |
Net Interest Expenses | $54.4M | $54.6M | $60.1M | $68M | $72.1M | |
EBT. Incl. Unusual Items | $68.8M | $71.9M | $90.1M | $92.3M | $109M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $7M | $10.3M | $8.5M | $7.1M | $10.2M | |
Net Income to Company | $61.7M | $61.6M | $81.6M | $85.2M | $98.8M | |
Minority Interest in Earnings | $114K | $107K | -$248K | -- | -- | |
Net Income to Common Excl Extra Items | $61.9M | $61.7M | $81.4M | $85.2M | $98.8M | |
Basic EPS (Cont. Ops) | $2.16 | $2.06 | $2.68 | $2.67 | $2.99 | |
Diluted EPS (Cont. Ops) | $2.15 | $2.05 | $2.66 | $2.66 | $2.98 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $216.2M | $227.5M | $255.4M | $270.4M | $296.9M | |
EBIT | $123.2M | $126.6M | $150.2M | $160.2M | $181.1M | |
Revenue (Reported) | $563.6M | $583.2M | $633.7M | $682.4M | $766.7M | |
Operating Income (Reported) | $115.3M | $103.9M | $138.8M | $152.2M | $178.5M | |
Operating Income (Adjusted) | $123.2M | $126.6M | $150.2M | $160.2M | $181.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $114.8M | $124.3M | $137.3M | $149.4M | $167.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $49.9M | $53M | $53.1M | $58.5M | $66.5M | |
Gross Profit | $64.9M | $71.3M | $84.2M | $90.9M | $101.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $20.9M | $24.2M | $24.3M | $25.8M | $27.8M | |
Other Inc / (Exp) | $2.1M | $7.4M | $3.2M | $3.6M | $2.4M | |
Operating Expenses | $51.8M | $60.1M | $59M | $63M | $65.2M | |
Operating Income | $13.1M | $11.1M | $25.2M | $27.9M | $35.9M | |
Net Interest Expenses | $13.4M | $13.7M | $15.8M | $17.6M | $18.3M | |
EBT. Incl. Unusual Items | $1.7M | $4.8M | $12.6M | $13.9M | $20M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$896K | $1.1M | $1.1M | $2.2M | $3.5M | |
Net Income to Company | $2.6M | $3.7M | $11.5M | $11.7M | $16.6M | |
Minority Interest in Earnings | $38K | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $2.7M | $3.7M | $11.5M | $11.7M | $16.6M | |
Basic EPS (Cont. Ops) | $0.09 | $0.12 | $0.37 | $0.36 | $0.49 | |
Diluted EPS (Cont. Ops) | $0.09 | $0.12 | $0.37 | $0.36 | $0.49 | |
Weighted Average Basic Share | $28.9M | $30.2M | $30.9M | $32.1M | $33.8M | |
Weighted Average Diluted Share | $29M | $30.3M | $31M | $32.1M | $33.9M | |
EBITDA | $39.1M | $46.6M | $55.2M | $60.4M | $67.9M | |
EBIT | $15.2M | $18.5M | $28.4M | $31.5M | $38.3M | |
Revenue (Reported) | $114.8M | $124.3M | $137.3M | $149.4M | $167.6M | |
Operating Income (Reported) | $13.1M | $11.1M | $25.2M | $27.9M | $35.9M | |
Operating Income (Adjusted) | $15.2M | $18.5M | $28.4M | $31.5M | $38.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $5.3M | $10.9M | $12.3M | $9.7M | $11.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $46.8M | $53.7M | $59.2M | $67.9M | $68.7M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $8.1M | $9.7M | $9.8M | $11.1M | $10.3M | |
Other Current Assets | $6.9M | $7.5M | $25.8M | $10.4M | $26.8M | |
Total Current Assets | $127.3M | $134.1M | $158.4M | $198.4M | $190.7M | |
Property Plant And Equipment | $2.3B | $2.5B | $2.6B | $3.2B | $3.4B | |
Long-Term Investments | $14.4M | $15.8M | $14.8M | $16.4M | $18.1M | |
Goodwill | $628.1M | $640.5M | $640.3M | $640.3M | $640.3M | |
Other Intangibles | $35.2M | $20.7M | $36M | $43.4M | $42.1M | |
Other Long-Term Assets | $6.9M | $10.9M | $7.3M | $8.1M | $28.9M | |
Total Assets | $3.3B | $3.5B | $3.8B | $4.3B | $4.7B | |
Accounts Payable | $34.2M | $30.4M | $29.6M | $46.1M | $56.3M | |
Accrued Expenses | $46.1M | $43M | $45.5M | $52.5M | $57.8M | |
Current Portion Of Long-Term Debt | $76.2M | $39.1M | $4.4M | $49M | $3.6M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $19.2M | $27.8M | $26.6M | $23.9M | $24.4M | |
Total Current Liabilities | $350.8M | $203.3M | $268.3M | $343M | $261.2M | |
Long-Term Debt | $1.3B | $1.5B | $1.5B | $1.5B | $1.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.4B | $2.5B | $2.6B | $3.1B | $3.3B | |
Common Stock | $29K | $30K | $31K | $32K | $34K | |
Other Common Equity Adj | -$1.1M | -$163K | $1.5M | $1.8M | $2M | |
Common Equity | $917.2M | $1B | $1.1B | $1.2B | $1.4B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $917.2M | $1B | $1.1B | $1.2B | $1.4B | |
Total Liabilities and Equity | $3.3B | $3.5B | $3.8B | $4.3B | $4.7B | |
Cash and Short Terms | $5.3M | $10.9M | $12.3M | $9.7M | $11.1M | |
Total Debt | $1.5B | $1.6B | $1.7B | $1.7B | $1.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $11.4M | $17.5M | $23.3M | $4.5M | $23.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $45.6M | $53.9M | $56.5M | $62.6M | $65.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $10.6M | $11.3M | $11.4M | $12.8M | $13.3M | |
Other Current Assets | $5.3M | $8.4M | $16.2M | $7.8M | $24.5M | |
Total Current Assets | $123.5M | $137.9M | $193.8M | $178.1M | $197.3M | |
Property Plant And Equipment | $2.3B | $2.5B | $2.6B | $3.2B | $3.5B | |
Long-Term Investments | $15.2M | $15.9M | $15.9M | $17.4M | $18.6M | |
Goodwill | $628.1M | $640.3M | $640.3M | $640.3M | $640.3M | |
Other Intangibles | $35.2M | $36.3M | $35.9M | $64.3M | $51.6M | |
Other Long-Term Assets | $5.7M | $11.5M | $19.7M | $8.2M | $28.7M | |
Total Assets | $3.3B | $3.5B | $3.7B | $4.4B | $4.7B | |
Accounts Payable | $25.6M | $28.4M | $26M | $34.4M | $46.7M | |
Accrued Expenses | $47.2M | $46.6M | $39.9M | $45.1M | $53.4M | |
Current Portion Of Long-Term Debt | $76.3M | $38.9M | $44.3M | $9M | $18.7M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $19.1M | $28M | $25.8M | $24M | $25.4M | |
Total Current Liabilities | $289.7M | $217.9M | $213M | $323.3M | $296.7M | |
Long-Term Debt | $1.3B | $1.5B | $1.5B | $1.6B | $1.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.4B | $2.5B | $2.5B | $3.1B | $3.3B | |
Common Stock | $30K | $30K | $31K | $32K | $34K | |
Other Common Equity Adj | -$1M | -$344K | $1.6M | $1.3M | $2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $978.3M | $1B | $1.2B | $1.2B | $1.4B | |
Total Liabilities and Equity | $3.3B | $3.5B | $3.7B | $4.4B | $4.7B | |
Cash and Short Terms | $11.4M | $17.5M | $23.3M | $4.5M | $23.7M | |
Total Debt | $1.5B | $1.6B | $1.6B | $1.8B | $1.9B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $61.5M | $60.5M | $73.8M | $85M | $94M | |
Depreciation & Amoritzation | $91.6M | $96.5M | $106.4M | $108.1M | $115.1M | |
Stock-Based Compensation | $3.6M | $4.2M | $4.8M | $4.6M | $5.6M | |
Change in Accounts Receivable | -$18.9M | -$5.9M | -$8.2M | -$10.9M | -$12.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $104.1M | $130M | $166.2M | $190.8M | $195.5M | |
Capital Expenditures | $215M | $253.8M | $244.2M | $290.7M | $380.6M | |
Cash Acquisitions | $1.2M | -$23.6M | -$433K | -$7.5M | -- | |
Cash From Investing | -$214.3M | -$260M | -$244.3M | -$322.3M | -$340.1M | |
Dividends Paid (Ex Special Dividend) | -$36.5M | -$40.1M | -$43.6M | -$47.9M | -$52.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $361.2M | $343.6M | $213.8M | $216.4M | $427.3M | |
Long-Term Debt Repaid | -$247.2M | -$284.8M | -$151.4M | -$138.8M | -$344.2M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $24.1M | $23.1M | $20.4M | $18.5M | $30M | |
Cash From Financing | $101.5M | $132.8M | $78.4M | $128.8M | $146M | |
Beginning Cash (CF) | $17.9M | $9.3M | $12.1M | $12.3M | $9.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$8.7M | $2.9M | $225K | -$2.6M | $1.4M | |
Ending Cash (CF) | $9.3M | $10.9M | $12.3M | $9.7M | $11.1M | |
Levered Free Cash Flow | -$110.9M | -$123.8M | -$78M | -$99.9M | -$185.1M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $20.8M | $11.6M | $18.3M | $20.7M | -- | |
Depreciation & Amoritzation | $24.5M | $25.7M | $26.7M | $28.9M | -- | |
Stock-Based Compensation | $791K | $1M | $1.1M | $1.3M | -- | |
Change in Accounts Receivable | -$15.5M | -$12.8M | -$11.9M | -$21.7M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $33.7M | $38.3M | $46.8M | $49.3M | -- | |
Capital Expenditures | $56.5M | $67.2M | $70.3M | $97.3M | -- | |
Cash Acquisitions | -$1.5M | -- | -- | -- | -- | |
Cash From Investing | -$55.1M | -$67.7M | -$70.4M | -$56.7M | -- | |
Dividends Paid (Ex Special Dividend) | -$10.1M | -$10.9M | -$11.9M | -$12.9M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $87M | $88.3M | $27.6M | $64M | -- | |
Long-Term Debt Repaid | -$50.5M | -$58.4M | -$17.3M | -$57.8M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $9M | $4.9M | $4.6M | $7M | -- | |
Cash From Financing | $34.9M | $23.9M | $25.7M | $25.7M | -- | |
Beginning Cash (CF) | $14.5M | $17.5M | $23.3M | $4.5M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $13.6M | -$5.4M | $2.1M | $18.3M | -- | |
Ending Cash (CF) | $25.4M | $12M | $25.5M | $22.8M | -- | |
Levered Free Cash Flow | -$22.8M | -$28.9M | -$23.5M | -$48M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $61.7M | $61.6M | $81.6M | $85.2M | $98.8M | |
Depreciation & Amoritzation | $93.1M | $100.6M | $105.2M | $110.2M | $115.8M | |
Stock-Based Compensation | $4.6M | $4.5M | $4.4M | $5M | $5.3M | |
Change in Accounts Receivable | -$16.7M | -$9.3M | -$4.4M | -$7.1M | -$19.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $129.5M | $142M | $171.5M | $191.4M | $187.5M | |
Capital Expenditures | $224.5M | $251.6M | $249.9M | $309.7M | $391.1M | |
Cash Acquisitions | $1.2M | -$23.6M | -$433K | -$7.5M | -- | |
Cash From Investing | -$223.7M | -$257.5M | -$249.9M | -$341.5M | -$350.6M | |
Dividends Paid (Ex Special Dividend) | -$37.1M | -$41.3M | -$44.4M | -$49M | -$53.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $324.4M | $313.4M | $280.6M | $246.8M | $382.1M | |
Long-Term Debt Repaid | -$296.2M | -$205M | -$248.2M | -$128.8M | -$289M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $22.1M | $28.3M | $15.5M | $15.6M | $38.1M | |
Cash From Financing | $80.5M | $119.1M | $83.6M | $131.3M | $182.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$13.8M | $3.6M | $5.2M | -$18.8M | $19.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$95.1M | -$109.7M | -$78.4M | -$118.3M | -$203.7M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $23.4M | $15.3M | $29.8M | $32.4M | $16.6M | |
Depreciation & Amoritzation | $48.4M | $53.8M | $53.5M | $57.8M | $29.6M | |
Stock-Based Compensation | $2.1M | $2.6M | $2.3M | $2.8M | $1.2M | |
Change in Accounts Receivable | -$7.8M | -$8.5M | -$3.7M | -$9.7M | $5.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $67.1M | $83.6M | $97.4M | $100.5M | $43.2M | |
Capital Expenditures | $108.3M | $116.8M | $125.5M | $171.6M | $84.8M | |
Cash Acquisitions | -$1.5M | -- | -- | -- | -- | |
Cash From Investing | -$107M | -$117.1M | -$125.4M | -$131M | -$84.8M | |
Dividends Paid (Ex Special Dividend) | -$19.9M | -$21.8M | -$23.7M | -$25.7M | -$14.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $132.7M | $103.7M | $109.8M | $176.7M | $67.4M | |
Long-Term Debt Repaid | -$133.8M | -$61.9M | -$117.7M | -$148M | -$35M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $13M | $14.1M | $8.9M | $8.3M | $9.4M | |
Cash From Financing | $58.7M | $34.1M | $41.1M | $43.5M | $54.2M | |
Beginning Cash (CF) | $23.8M | $29.6M | $35.7M | $14.3M | $11.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $18.8M | $532K | $13.1M | $13.1M | $12.6M | |
Ending Cash (CF) | $40M | $29.5M | $48.8M | $27.3M | $23.7M | |
Levered Free Cash Flow | -$41.2M | -$33.2M | -$28.1M | -$71M | -$41.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.